Yayasan Sime Darby (YSD) has committed to fund clinical trials led by University Malaysia Medical Centre (UMMC) to treat severe COVID-19 cases utilising Tocilizumab (TCZ), a medication used to treat rheumatoid arthritis, in the fight against the COVID-19 pandemic.